MX2007004400A - Procedimiento para la preparacion de n-(3,5-dicloropirid-a-il)-4- ifluorometoxi-8-metanosulfonamido-dibenzo [b,d] difuran-1-carboxamida. - Google Patents
Procedimiento para la preparacion de n-(3,5-dicloropirid-a-il)-4- ifluorometoxi-8-metanosulfonamido-dibenzo [b,d] difuran-1-carboxamida.Info
- Publication number
- MX2007004400A MX2007004400A MX2007004400A MX2007004400A MX2007004400A MX 2007004400 A MX2007004400 A MX 2007004400A MX 2007004400 A MX2007004400 A MX 2007004400A MX 2007004400 A MX2007004400 A MX 2007004400A MX 2007004400 A MX2007004400 A MX 2007004400A
- Authority
- MX
- Mexico
- Prior art keywords
- dichloropyrid
- methanesulfonamido
- dibenzo
- carboxamide
- diflufuran
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61847404P | 2004-10-13 | 2004-10-13 | |
| IN1099MU2004 | 2004-10-14 | ||
| US62198104P | 2004-10-21 | 2004-10-21 | |
| PCT/IB2005/003035 WO2006040652A2 (en) | 2004-10-13 | 2005-10-12 | Process for the preparation of n-(3,5-dichloropyrid-4-yl)-4difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007004400A true MX2007004400A (es) | 2007-06-19 |
Family
ID=35911095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007004400A MX2007004400A (es) | 2004-10-13 | 2005-10-12 | Procedimiento para la preparacion de n-(3,5-dicloropirid-a-il)-4- ifluorometoxi-8-metanosulfonamido-dibenzo [b,d] difuran-1-carboxamida. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7563900B2 (de) |
| EP (1) | EP1799632A2 (de) |
| JP (1) | JP2009519206A (de) |
| AR (1) | AR051933A1 (de) |
| AU (1) | AU2005293293A1 (de) |
| BR (1) | BRPI0516341A (de) |
| CA (1) | CA2583497A1 (de) |
| IL (1) | IL182445A0 (de) |
| MX (1) | MX2007004400A (de) |
| WO (1) | WO2006040652A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7511150B2 (en) * | 2006-07-06 | 2009-03-31 | Forest Laboratories Holdings Limited | Synthesis of heterocyclic compounds |
| WO2008065522A2 (en) * | 2006-11-29 | 2008-06-05 | Glenmark Pharmaceuticals S.A. | Process for the synthesis of 4-difluoromethoxy-8-nitro-1-formyl dibenzo[b,d] furan-an intermediate for pde iv inhibitors |
| US8524905B2 (en) | 2007-05-22 | 2013-09-03 | Glenmark Pharmaceuticals S.A. | Processes for preparing 6-(difluoromethoxy)[1]benzofuro[3,2-c]pyridine-9-carbaldehyde, a novel intermediate for the synthesis of PDE IV inhibitors |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1041861A (en) | 1962-03-14 | 1966-09-07 | Organon Labor Ltd | Pyrrolidone derivatives and pharmaceutical preparations containing them |
| NL7008628A (de) | 1969-06-25 | 1970-12-29 | ||
| US3759948A (en) | 1969-06-25 | 1973-09-18 | Merck & Co Inc | Non-steroid anti-inflammatory compounds |
| NL7016899A (de) | 1969-12-03 | 1971-06-07 | ||
| US4222944A (en) | 1978-07-31 | 1980-09-16 | Hoffmann-La Roche Inc. | Halo-3-dibenzofuran alkanonitriles |
| HU193194B (en) * | 1984-01-17 | 1987-08-28 | Budapesti Vegyimuevek | Fungicide compositions containing phenoxy-benzaldehyde derivatives as active substances and process for preparing the active substances |
| JPS62158253A (ja) | 1985-12-28 | 1987-07-14 | Kirin Brewery Co Ltd | ４−アミノピリジンアミド誘導体 |
| US5202344A (en) | 1990-12-11 | 1993-04-13 | G. D. Searle & Co. | N-substituted lactams useful as cholecystokinin antagonists |
| IE71647B1 (en) | 1991-01-28 | 1997-02-26 | Rhone Poulenc Rorer Ltd | Benzamide derivatives |
| JP3195352B2 (ja) | 1992-04-02 | 2001-08-06 | スミスクライン・ビーチャム・コーポレイション | アレルギーおよび炎症疾患の治療用化合物 |
| MX9304571A (es) | 1992-07-28 | 1994-05-31 | Rhone Poulenc Rorer Ltd | Compuestos fanilicos ligados a un arilo o heteroarilo mediante un radical alifatico o un atomo heterogeneo que contiene un grupo eslabonador. |
| MX9306311A (es) | 1992-10-13 | 1994-04-29 | Smithkline Beecham Plc | Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen |
| US5814651A (en) | 1992-12-02 | 1998-09-29 | Pfizer Inc. | Catechol diethers as selective PDEIV inhibitors |
| GB9304920D0 (en) | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
| CA2165192C (en) | 1993-07-02 | 2001-04-24 | Hermann Amschler | Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
| GB9315595D0 (en) | 1993-07-28 | 1993-09-08 | Res Inst Medicine Chem | New compounds |
| WO1995009837A1 (en) | 1993-10-01 | 1995-04-13 | Smithkline Beecham Corporation | Cyano compounds |
| GB9401460D0 (en) | 1994-01-26 | 1994-03-23 | Rhone Poulenc Rorer Ltd | Compositions of matter |
| GB9404706D0 (en) | 1994-03-11 | 1994-04-27 | Smithkline Beecham Corp | Compounds |
| US6514996B2 (en) | 1995-05-19 | 2003-02-04 | Kyowa Hakko Kogyo Co., Ltd. | Derivatives of benzofuran or benzodioxole |
| JP2000517341A (ja) | 1996-09-04 | 2000-12-26 | ワーナー―ランバート・コンパニー | マトリックスメタロプロテイナーゼ阻害剤およびそれらの治療的使用 |
| EP1064298B1 (de) | 1998-03-19 | 2008-10-08 | Vertex Pharmaceuticals Incorporated | Caspase inhibitoren |
| US6887870B1 (en) | 1999-10-12 | 2005-05-03 | Bristol-Myers Squibb Company | Heterocyclic sodium/proton exchange inhibitors and method |
| NZ521248A (en) | 2000-03-17 | 2004-04-30 | Bristol Myers Squibb Pharma Co | Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha |
| CA2404226A1 (en) | 2000-03-23 | 2001-09-27 | Takeda Chemical Industries, Ltd. | Furoisoquinoline derivatives, process for producing the same and use thereof |
| AU2002228316A1 (en) | 2001-01-29 | 2002-08-12 | Insight Strategy And Marketing Ltd | Carbazole derivatives and their uses as heparanase inhibitors |
| AU2002306687A1 (en) | 2001-03-13 | 2002-09-24 | Glenmark Pharmaceuticals Limited | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| AU2003253130A1 (en) | 2002-08-19 | 2004-03-03 | Glenmark Pharmaceuticals Limited | Condensed heterocyclic compounds as pde-iv inhibitors for the treatment of inflammatory and allergic disorders |
| AU2003263393A1 (en) | 2002-09-04 | 2004-03-29 | Glenmark Pharmaceuticals Limited | New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| DE60317918T2 (de) * | 2002-10-23 | 2009-01-29 | Glenmark Pharmaceuticals Ltd. | Tricyclische verbindungen zur behandlung von entzündlichen und allergischen erkrankungen verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen |
| BRPI0409747A (pt) * | 2003-04-11 | 2006-05-09 | Glenmark Pharmaceuticals Sa | novos compostos heterocìclicos úteis para tratamento de distúrbios inflamatórios e alérgicos, processo para sua preparação e composições farmacêuticas contendo estes |
-
2005
- 2005-10-12 MX MX2007004400A patent/MX2007004400A/es unknown
- 2005-10-12 CA CA002583497A patent/CA2583497A1/en not_active Abandoned
- 2005-10-12 BR BRPI0516341-2A patent/BRPI0516341A/pt not_active IP Right Cessation
- 2005-10-12 WO PCT/IB2005/003035 patent/WO2006040652A2/en active Application Filing
- 2005-10-12 AU AU2005293293A patent/AU2005293293A1/en not_active Abandoned
- 2005-10-12 JP JP2007536282A patent/JP2009519206A/ja active Pending
- 2005-10-12 AR ARP050104283A patent/AR051933A1/es unknown
- 2005-10-12 EP EP05819677A patent/EP1799632A2/de not_active Withdrawn
- 2005-10-13 US US11/251,567 patent/US7563900B2/en not_active Expired - Fee Related
-
2007
- 2007-04-10 IL IL182445A patent/IL182445A0/en unknown
-
2009
- 2009-07-17 US US12/505,087 patent/US20090281146A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006040652A2 (en) | 2006-04-20 |
| WO2006040652A3 (en) | 2006-10-26 |
| US7563900B2 (en) | 2009-07-21 |
| US20060135779A1 (en) | 2006-06-22 |
| AR051933A1 (es) | 2007-02-21 |
| AU2005293293A1 (en) | 2006-04-20 |
| IL182445A0 (en) | 2007-07-24 |
| BRPI0516341A (pt) | 2008-09-02 |
| CA2583497A1 (en) | 2006-04-20 |
| EP1799632A2 (de) | 2007-06-27 |
| JP2009519206A (ja) | 2009-05-14 |
| US20090281146A1 (en) | 2009-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1081199A1 (en) | Process and intermediates for the preparation of (1r,2s,5s)-6,6-dimethyl-3- azabicyclo [3,1,0] hexane-2-carboxylates or salts thereof | |
| TW200736258A (en) | Pyrimidine derivatives for the treatment of abnormal cell growth | |
| MX2007004637A (es) | Sintesis asimetrica de derivados de dihidrobenzofurano. | |
| MX2007007845A (es) | Sulfonilpirrolidinas, metodo para producir las mismas y su uso como medicamento. | |
| UA80834C2 (en) | Method of synthesising ivabradine and the salts thereof for addition to a pharmaceutically acceptable acid | |
| HK1089444A1 (en) | Dihydropteridinones, method for the production and use thereof in the form of drugs | |
| TW200728307A (en) | Novel spirochromanone derivatives | |
| MY139399A (en) | Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist | |
| MX2009004900A (es) | Arilamidas sustituidas por tiazol u oxazol. | |
| WO2008120725A1 (ja) | 新規ピロリノン誘導体およびそれを含有する医薬組成物 | |
| WO2006025070A3 (en) | Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol | |
| GEP20104964B (en) | 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof | |
| TW200702330A (en) | 3,4,5-Substituted piperidines | |
| MXPA05013751A (es) | Procedimiento e intermediarios para la preparacion de 3-(amino)-3-ciclobutilmetil-2-hidroxi-propionamida o sus sales. | |
| JO2413B1 (en) | Benzoxazine derivatives and their use | |
| MY186650A (en) | Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives | |
| PL1831191T3 (pl) | Pochodne chromanu i ich zastosowanie jako ligandów receptorów 5-HT | |
| TW200704633A (en) | Process for the preparation of sulfonamide derivatives | |
| TW200635905A (en) | Processes for producing 4-aminoquinazolines | |
| MX2007003922A (es) | Nuevas propenonas ciclicas y aciclicas para tratar trastornos del sistema nervioso central. | |
| TW200833371A (en) | Process for solid formulations | |
| WO2004111008A3 (en) | Use of a compound of formula i for making a pharmaceutical composition | |
| MX2007004400A (es) | Procedimiento para la preparacion de n-(3,5-dicloropirid-a-il)-4- ifluorometoxi-8-metanosulfonamido-dibenzo [b,d] difuran-1-carboxamida. | |
| WO2008059513A3 (en) | Compounds suitable as modulators of hdl | |
| TW200616991A (en) | Process for the preparation of n-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methane sulfonamido-dibenzo[b,d]furan-1-carboxamide |